Tag: calviri
-
Calviri Taking the Next Steps to Help a Man’s Best Friend
Phoenix, AZ (October 15, 2025) – In the United States, an estimated six million dogs are diagnosed with cancer every year, making it the leading cause of death in adult […]
-
CoLab Meeting from 7/16/25
Held at 850 Phoenix Bioscience Core (PBC) in the Center for Entrepreneurial Innovation (CEI) space, lab managers, techs, and operators share resources, solve problems, and drive innovation across the PBC […]
-
Inside BIO 2025: Big Wins and Bigger Momentum for Phoenix and the PBC
Bio2025 Last week, the Phoenix Bioscience Core (PBC) joined a powerful Arizona delegation for the 2025 BIO International Convention — the largest biotechnology conference in the world, with over 20,000 […]
-
Calviri Publishes Results Demonstrating Sensitive Detection of Stage 1 Tumors in Dogs
PHOENIX, June 17, 2025 /PRNewswire/ — Calviri, Inc, a company focused on ending cancer in dogs and people, announces the publication of High-sensitivity multicancer detection of stage 1 cancer in dogs in the American Journal […]
-
Calviri: Canines Are Leading the Fight Against Human Cance
Calviri Inc. CEO Dr. Stephen Johnston recently wrote an article in Pharmacy Times discussing how important the relationship is between canines and humans in the fight against cancer. Calviri, an […]
-
Calviri Scientists Find New Class of Biomarkers for Predicting Treatment Response in Cancer Patients
Researchers at Calviri have discovered a new biomarker in lung cancer patients that could better predict treatment response.
-
Meet Calviri: The PBC company developing a vaccine for cancer
Calviri, Inc. is a Phoenix Bioscience Core-based company is working on a vaccine for cancer – yes, you read that correctly.
-
PBC Company Calviri announces enrollment of 800 dogs in preventative cancer vaccine trial
Vaccine Against Canine Cancer Study (VACCS), with 800 dogs, making it the largest interventional canine clinical trial in the history of veterinary medicine.
-
Calviri CEO Dr. Stephen Johnston on cancer eradication
Phoenix Bioscience Core-based Calviri Inc.’s founder Dr. Stephen Johnston recently spoke to Progress, Potential and Possibilities on eradicating cancer via a universival preventative cancer vaccine.
-
Calviri announces new scientific advisory board
The newly formed Scientific Advisory Board will collaborate closely with Calviri’s senior leadership team and support the advancement of the company’s diversified portfolio of diagnostic platforms and therapeutic cancer vaccines pipeline targeting both human and animal health.
